Discovery and Development of Oral Small-molecule Direct-acting Antivirals
$1,999,195N44FY2025AINIH
Collaborations Pharmaceuticals, Inc., Fuquay Varina NC
Investigators
Abstract
The objective is to develop an oral treatment for Ebola virus infection in humans.
View original record on NIH RePORTER →